FDA Approves The First Covid-19 Vaccine

Today, the U.S. Food and Drug Administration approved the first COVID-19 vaccine. The vaccine has been known as the Pfizer-BioNTech COVID-19 Vaccine, and will now be marketed as Comirnaty (koe-mir’-na-tee), for the prevention of COVID-19 disease in individuals 16 years of age and older. The vaccine also continues to be available under emergency use authorization (EUA), including for individuals 12 through 15 years of age and for the administration of a third dose in certain immunocompromised individuals.
 
The public can be very confident that this vaccine meets the high standards for safety, effectiveness, and manufacturing quality the FDA requires of an approved product.The FDA approval of the vaccine may now instill additional confidence to get vaccinated for those who remain unvaccinated. It will also open doors to mandating vaccines by employers.
Author
Mahesh S. Ochaney, MD

You Might Also Enjoy...

The Latest on Omicron Variant

The Omicron variant of the coronavirus is on track to be the dominant strain of the virus in the United States, replacing the highly transmissible delta variant.

Covid Antiviral Drugs

Two antiviral medications to treat COVID-19 are awaiting authorization from the Food and Drug Administration (FDA).

COVID Booster Shots

Here's Everything You Need To Know If You're Totally Confused About COVID Booster Shots.